Dokkyo Medical University · Faculty of Medicine

Research keywordsInternal・Heart・Xanthine・oxidase・Cardiology・failure・medicine・Hyperuricemia

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial., Sakuma Masashi;Toyoda Shigeru;Arikawa Takuo;Koyabu Yota;Kato Toru;Adachi Taichi;Suwa Hideaki;Narita Jun-Ichi;Anraku Koetsu;Ishimura Kimihiko;Yamauchi Fumitake;Sato Yasunori;Inoue Teruo, PloS one, 17（1）, e0261445, 2022年01月25日2022 · 論文
• Optimal uric acid reduction to improve vascular endothelial function in patients with chronic heart failure complicated by hyperuricemia., Naganuma Jin;Sakuma Masashi;Kitahara Keijiro;Kato Toru;Yokomachi Jun;Yamauchi Fumitake;Inoue Riri;Iida Keitaro;Kohno Yuto;Inoue Koki;Koshiji Nobuo;Abe Shichiro;Toyoda Shigeru;Inoue Teruo; , Hypertension research : official journal of the Japanese Society of Hypertension, 46（3）, 688-696, 2022年12月20日2022 · 論文
• The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol., Sakuma M, Toyoda S, Arikawa T, Koyabu Y, Kato T, Adachi T, Suwa H, Narita JI, Anraku K, Ishimura K, Yamauchi F, Sato Y, Inoue T; For Excited UA study Investigators., Clin Exp Nephrol, 22, 1379-1386, 2018年06月2018 · 論文
• Anti-atherosclerotic effect of eicosapentaenoic acid in patients undergoing percutaneous coronary intervention., Nishida H, Abe S, Tajima E, Saito F, Koyabu Y, Fukuda R, Yamauchi F, Sakuma M, Toyoda S, Kikuchi M, Inoue T., J Clin Physiol, 46（1）, 21-29, 2016年02月2016 · 論文

• Official profile